Fig. 2

Efficacy evaluation in thalidomide. A–B Heatmaps showing the number of patients with different outcomes before and after thalidomide treatment. The horizontal axis represents the disease type, with baseline conditions on the left and endpoints on the right. The vertical axis represents clinical, laboratory, and treatment features. The color intensity reflects different numerical values, darker colors indicating higher values. A Baseline and 3 months after thalidomide treatment in 16 patients. B Baseline and 12 months after thalidomide treatment in 12 patients. C Efficacy rate after 3 months of thalidomide treatment. The number above the bar graph is the ratio of the patients with effective treatment out of all patients with different types of AIDs. D Efficacy rate after 12 months of thalidomide treatment. The number above the bar graph is the ratio of the patients with effective treatment out of all patients with different types of AIDs